Sort
15,842 grants matching “pancreatic cancer”
Cell Cycle Regulators in Diabetes and Obesity
$384,368Sushil Rane · National Institute Of Diabetes And Digestive And Kidney Diseases · Z01 · FY2008 · DK
Ultrasenstive vesicle analysis in precancerous pancreatic neoplasm (IPMN)
$384,300Ralph Weissleder · Massachusetts General Hospital · R01 · FY2020 · CA
Ultrasenstive vesicle analysis in precancerous pancreatic neoplasm (IPMN)
$384,300Ralph Weissleder · Massachusetts General Hospital · R01 · FY2021 · CA
Targeting metabolic stress to induce pancreatic tumor cell death
$384,227Costas Andreas Lyssiotis · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
Surgical Studies of Pancreatic Stem Cells
$384,225Johns Hopkins University · R01 · FY2005 · DK
Exosomes in Cancer Therapy
$384,147Raghu Kalluri · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · CA
Exosomes in Cancer Therapy
$384,147Raghu Kalluri · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · CA
Exosomes in Cancer Therapy
$384,147Raghu Kalluri · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
CPML - Project 3: Genome-wide Studies of Adverse Effects
$384,140Mary V. Relling · St. Jude Children'S Research Hospital · P50 · FY2016 · GM
Center for Modeling Tumor Cell Migration Mechanics: Administrative Core
$384,080David J Odde · University Of Minnesota · U54 · FY2016 · CA
Dosage-Dependent Hedgehog Signaling in Pancreatic Cancer
$384,048Benjamin Allen · University Of Michigan At Ann Arbor · R01 · FY2016 · CA
High dose radiation therapy to direct immune responses to pancreatic cancer
$384,038Michael James Gough · Providence Portland Medical Center · R01 · FY2023 · CA
High dose radiation therapy to direct immune responses to pancreatic cancer
$384,038Michael James Gough · Providence Portland Medical Center · R01 · FY2022 · CA
High Throughput Digital Droplet Assays for Ultrasensitive Multimodal (DNA, RNA, and Protein) Diagnostics
$383,922David Aaron Issadore · University Of Pennsylvania · R33 · FY2025 · CA
Biased chemokine receptor signaling in cancer progression
$383,920Michael B Dwinell · Medical College Of Wisconsin · R01 · FY2022 · CA
Mechanisms of the spliceosome protein SF3B1 and inhibitors
$383,849Melissa S Jurica · University Of California Santa Cruz · R01 · FY2017 · GM
Biased chemokine receptor signaling in cancer progression
$383,766Michael B Dwinell · Medical College Of Wisconsin · R01 · FY2023 · CA
Mechanisms of islet transplant immune tolerance
$383,750Midhat H Abdulreda · University Of Miami School Of Medicine · R56 · FY2017 · AI
Reprogramming the Tumor Microenvironment in Pancreas Cancer to Enhance Immunotherapy
$383,750Nipun B. Merchant · University Of Miami School Of Medicine · R01 · FY2020 · CA
Reprogramming the Tumor Microenvironment in Pancreas Cancer to Enhance Immunotherapy
$383,750Nipun B. Merchant · University Of Miami School Of Medicine · R01 · FY2021 · CA
Development of Quinoxaline Based IKKbeta Inhibitors for Kras Driven Cancers
$383,750Amarnath Natarajan · University Of Nebraska Medical Center · R01 · FY2023 · CA
Priming pancreatic ductal adenocarcinoma using blood thinners to sensitize the efficacy of checkpoint immunotherapy
$383,750Taslim A Al-Hilal · University Of Texas El Paso · SC1 · FY2023 · GM
Development of Quinoxaline Based IKKbeta Inhibitors for Kras Driven Cancers
$383,749Amarnath Natarajan · University Of Cincinnati · R01 · FY2025 · CA
Education Program in Cancer Prevention
$383,693Joel L Weissfeld · University Of Pittsburgh At Pittsburgh · R25 · FY2007 · CA
Delineating the contribution of muscle wasting to tumor progression
$383,570Jason Doles · Indiana University Indianapolis · R21 · FY2023 · AR